Home » Stock Quotes » CVE:ACST

Acasti Pharma Inc CVE:ACST

Today's live share price, quote history, chart & news

0.47 CAD
-0.03 (-6.00%)
Price open 0.50
Previous close 0.50
Market cap 42.40M
Volume 31.23K
Day high 0.50
Day low 0.47
Year high 4.05
Year low 0.35

About Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Name Acasti Pharma Inc
Exchange TSX Venture Exchange
Sector Healthcare
Industry Biotechnology
Country Canada
Full time employees 28

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.